Author:
Nikolic Milena,Matic Aleksa,Feka Joy,Gensthaler Lisa,Kristo Ivan,Osmokrovic Bogdan,Riegler Franz M.,Mosleh Berta O.,Schoppmann Sebastian F.
Abstract
Abstract
Background
Magnetic sphincter augmentation (MSA) is a modern surgical anti-reflux technique with proven efficacy and low postoperative morbidity in patients with acidic reflux. The aim of this retrospective review study was to evaluate the symptomatic outcome of MSA in patients with weakly acidic reflux.
Methods
From a prospectively collected clinical database, comprising all 327 patients that underwent MSA at our institution, a total of 67 patients with preoperative weakly acidic reflux measured in the 24-h impedance-pH-metry were identified. Postoperative gastrointestinal symptoms, proton pump inhibitor intake (PPI), GERD Health-Related Quality-of-Life (GERD-HRQL), alimentary satisfaction (AS), and patients’ overall satisfaction were evaluated within highly standardized follow-up appointments. Furthermore, outcome of these patients was compared to the postoperative outcome of a comparable group of patients with a preoperative acidic reflux.
Results
At a median follow-up of 24 months, none of the patients with weakly acidic reflux presented with persistent dysphagia, or underwent endoscopic dilatation or reoperation. The postoperative GERD-HRQL score was significantly reduced (2 vs. 20; p = 0.001) and the median AS was 9/10. Preoperative daily heartburn, regurgitations, and respiratory complaints were improved in 95%, 95%, and 96% of patients, respectively. A total of 10% of the patients continued to use PPIs postoperatively. No significant difference was observed in terms of postoperative outcome or quality of life when comparing weakly acidic reflux patients with those diagnosed with preoperative acidic reflux.
Conclusion
Magnetic sphincter augmentation significantly improves GERD-related symptoms and quality of life in patients with weakly acidic reflux with very low postoperative morbidity.
Funder
Medical University of Vienna
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Danilova DA, Bazaev AV, Gorbunova LI: [Current aspects of surgical treatment of gastro-esophageal reflux disease]. Khirurgiia (Mosk) 2020(2):89-94.
2. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, Global Consensus G: The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006, 101(8):1900–1920; quiz 1943.
3. Bakhos CT, Abbas AE, Petrov RV: Tailoring Endoscopic and Surgical Treatments for Gastroesophageal Reflux Disease. Gastroenterol Clin North Am 2020, 49(3):467-480.
4. Butt I, Kasmin F: Esophageal pH Monitoring. In: StatPearls. edn. Treasure Island (FL); 2020.
5. Moore M, Afaneh C, Benhuri D, Antonacci C, Abelson J, Zarnegar R: Gastroesophageal reflux disease: A review of surgical decision making. World J Gastrointest Surg 2016, 8(1):77-83.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献